Clinical trial
Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With…
NCT00040573 · TransMolecular, Industry · Completed
Key facts
| NCT number | NCT00040573 |
|---|---|
| Title | Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma. |
| Official title | A Phase I/II Open Label, Single Dose Study of Intracavitary Administered 131I-TM-601 in Adult Patients With Recurrent High-Grade Glioma. |
| Lead sponsor | TransMolecular, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Glioma, Brain Neoplasm |
| Intervention type | Drug |
| Interventions | 131I-TM-601 |
| Enrollment | 18 |
| Start date | Jun 1, 2002 |
| Completion | Aug 1, 2003 |
| First posted | Jul 2, 2002 |
| Last update posted | Mar 31, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: